Databases in the area of pharmacogenetics
- PMID: 21309040
- PMCID: PMC3352027
- DOI: 10.1002/humu.21454
Databases in the area of pharmacogenetics
Abstract
In the area of pharmacogenetics and personalized health care it is obvious that databases, providing important information of the occurrence and consequences of variant genes encoding drug metabolizing enzymes, drug transporters, drug targets, and other proteins of importance for drug response or toxicity, are of critical value for scientists, physicians, and industry. The primary outcome of the pharmacogenomic field is the identification of biomarkers that can predict drug toxicity and drug response, thereby individualizing and improving drug treatment of patients. The drug in question and the polymorphic gene exerting the impact are the main issues to be searched for in the databases. Here, we review the databases that provide useful information in this respect, of benefit for the development of the pharmacogenomic field.
© 2011 Wiley-Liss, Inc.
Similar articles
-
Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.Curr Pharm Biotechnol. 2017;18(3):274-281. doi: 10.2174/1389201018666170207124835. Curr Pharm Biotechnol. 2017. PMID: 28176638
-
How to Consider Rare Genetic Variants in Personalized Drug Therapy.Clin Pharmacol Ther. 2018 May;103(5):745-748. doi: 10.1002/cpt.976. Epub 2018 Jan 5. Clin Pharmacol Ther. 2018. PMID: 29313952
-
Personalized medicine: going to the dogs?Hum Genet. 2019 May;138(5):467-481. doi: 10.1007/s00439-019-02020-w. Epub 2019 Apr 28. Hum Genet. 2019. PMID: 31032534 Review.
-
Highly personalized reports for personalized drug selection by expert systems as clinical decision support.Per Med. 2017 Mar;14(2):93-97. doi: 10.2217/pme-2016-0083. Epub 2017 Jan 19. Per Med. 2017. PMID: 29754552 No abstract available.
-
Pharmacogenomics: Prescribing Precisely.Med Clin North Am. 2019 Nov;103(6):977-990. doi: 10.1016/j.mcna.2019.07.002. Epub 2019 Aug 24. Med Clin North Am. 2019. PMID: 31582008 Review.
Cited by
-
Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.PeerJ. 2021 Jul 15;9:e11774. doi: 10.7717/peerj.11774. eCollection 2021. PeerJ. 2021. PMID: 34316407 Free PMC article.
-
Polypharmacy: a healthcare conundrum with a pharmacogenetic solution.Crit Rev Clin Lab Sci. 2019 Nov 2;57(3):161-180. doi: 10.1080/10408363.2019.1678568. Crit Rev Clin Lab Sci. 2019. PMID: 31680605 Free PMC article.
-
Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons.PLoS Genet. 2017 Jul 12;13(7):e1006891. doi: 10.1371/journal.pgen.1006891. eCollection 2017 Jul. PLoS Genet. 2017. PMID: 28700616 Free PMC article.
-
Pharmacogenomics of chemotherapeutic susceptibility and toxicity.Genome Med. 2012 Nov 30;4(11):90. doi: 10.1186/gm391. eCollection 2012. Genome Med. 2012. PMID: 23199206 Free PMC article. Review.
-
PharmGKB: the Pharmacogenomics Knowledge Base.Methods Mol Biol. 2013;1015:311-20. doi: 10.1007/978-1-62703-435-7_20. Methods Mol Biol. 2013. PMID: 23824865 Free PMC article.
References
-
- Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB. Clinical assessment incorporating a personal genome. Lancet. 2010;375:1525–1535. - PMC - PubMed
-
- Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet. 1997;32:210–258. - PubMed
-
- Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics. 2010;11:607–611. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources